Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology

Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology

<i>Receptor tyrosine kinase erythroblastic oncogene B2</i> (<i>ERBB2</i>), also known as <i>human epidermal growth factor receptor 2</i> (<i>HER2</i>), represents an oncogenic driver and has been effectively targeted in breast and gastric cancer. Recen...

Full description

Bibliographic Details
Main Authors: Soeren M. Buchholz, Nelia Nause, Ute König, Johanna Reinecke, Benjamin Steuber, Christoph Ammer-Herrmenau, Kirsten Reuter-Jessen, Hanibal Bohnenberger, Lorenz Biggemann, Friederike Braulke, Albrecht Neesse, Volker Ellenrieder, Philipp Ströbel, Marius Adler, Alexander König
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Personalized Medicine
Subjects:
HER2
ERBB2
colorectal cancer
molecular tumor board
genomic profiling
targeted therapy
Online Access:https://www.mdpi.com/2075-4426/13/12/1701

Internet

https://www.mdpi.com/2075-4426/13/12/1701

Similar Items